These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 2766280

  • 1. Therapy of central nervous system leukemia in mice by liposome-entrapped 1-beta-D-arabinofuranosylcytosine.
    Hong F, Mayhew E.
    Cancer Res; 1989 Sep 15; 49(18):5097-102. PubMed ID: 2766280
    [Abstract] [Full Text] [Related]

  • 2. Stealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosine.
    Allen TM, Mehra T, Hansen C, Chin YC.
    Cancer Res; 1992 May 01; 52(9):2431-9. PubMed ID: 1568213
    [Abstract] [Full Text] [Related]

  • 3. Effect of cholesterol content on antitumor activity and toxicity of liposome-encapsulated 1-beta-D-arabinofuranosylcytosine in vivo.
    Ganapathi R, Krishan A, Wodinsky I, Zubrod CG, Lesko LJ.
    Cancer Res; 1980 Mar 01; 40(3):630-3. PubMed ID: 7471083
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of tumor cell growth in vitro and in vivo by 1-beta-D-arabinofuranosylcytosine entrapped within phospholipid vesicles.
    Mayhew E, Papahadjopoulos D, Rustum YM, Dave C.
    Cancer Res; 1976 Dec 01; 36(12):4406-11. PubMed ID: 187321
    [Abstract] [Full Text] [Related]

  • 5. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
    Early AP, Preisler HD, Slocum H, Rustum YM.
    Cancer Res; 1982 Apr 01; 42(4):1587-94. PubMed ID: 6949642
    [Abstract] [Full Text] [Related]

  • 6. Formulation, stability, and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugate of thioether phospholipid.
    Hong CI, Bernacki RJ, Hui SW, Rustum Y, West CR.
    Cancer Res; 1990 Jul 15; 50(14):4401-6. PubMed ID: 2364392
    [Abstract] [Full Text] [Related]

  • 7. Role of liposome type and route of administration in the antitumor activity of liposome-entrapped 1-beta-D-arabinofuranosylcytosine against mouse L1210 leukemia.
    Rustum YM, Dave C, Mayhew E, Papahadjopoulos D.
    Cancer Res; 1979 Apr 15; 39(4):1390-5. PubMed ID: 421223
    [No Abstract] [Full Text] [Related]

  • 8. Antitumor effects and pharmacology of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in mice.
    Hori K, Tsuruo T, Naganuma K, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1984 Jan 15; 44(1):172-7. PubMed ID: 6690034
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacology of 5'-esters of 1-beta-D-arabinofuranosylcytosine.
    Ho DH, Neil GL.
    Cancer Res; 1977 Jun 15; 37(6):1640-3. PubMed ID: 870178
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugated with polyglutamic acid and its derivative.
    Kato Y, Saito M, Fukushima H, Takeda Y, Hara T.
    Cancer Res; 1984 Jan 15; 44(1):25-30. PubMed ID: 6197162
    [Abstract] [Full Text] [Related]

  • 14. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
    Li ZR, Campbell J, Rustum YM.
    Cancer Treat Rep; 1983 Jun 15; 67(6):547-54. PubMed ID: 6190558
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Antitumor activity of a novel analog of cytarabine, 4-amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone 5'-(sodium octadecyl phosphate) monohydrate (YNK01)].
    Nagahata T, Shibasaki C, Ishii T, Uchida T, Arakawa M, Kusama K, Ekimoto H, Takahashi K.
    Gan To Kagaku Ryoho; 1990 Aug 15; 17(8 Pt 1):1437-45. PubMed ID: 2389942
    [Abstract] [Full Text] [Related]

  • 19. Combination effects of Ara-C and 5-fluorodeoxyuridine against leukemia cells in vitro and in mice.
    Rauko P, Bauer W, Horvath Z, Höchtl T, Saiko P, Karl D, Schott H, Fritzer-Szekeres M, Novotny L, Szekeres T.
    Anticancer Res; 2003 Aug 15; 23(5A):3841-6. PubMed ID: 14666686
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.